TD SYNNEX CORP (SNX) reports that BlackRock, Inc. beneficially owned 7,376,169 common shares, or 9.2%, as of September 30, 2026. BlackRock reported sole voting power over 7,102,919 shares and sole dispositive power over 7,376,169 shares, with no shared voting or dispositive power. The reported position reflects certain BlackRock business units and affiliates, excluding units whose holdings are disaggregated. Various persons may receive dividends or sale proceeds, but no one person's interest exceeds 5% of TD SYNNEX's outstanding common shares.
TD SYNNEX (SNX) Chief Human Resources Officer Dhanji Alim reported three direct sales of common stock on October 22, 2026, totaling 3,775 shares: 2,450 shares at a weighted average of $240.93, 1,243 at a weighted average of $241.14, and 82 at $241.20. Footnotes give price ranges of $240.92 to $240.98 for the first sale and $241.03 to $241.22 for the second. No Rule 10b5-1 plan is reported.
TD SYNNEX Corp. director and officer Dennis Polk, whose title is Chair, Hyve Solutions, exercised options covering 1,050 common shares at $106.35 per share and 2,905 common shares at $107.32 per share on October 21, 2026. He sold 3,955 common shares that day at a weighted average price of $251.27 per share; reported sale prices ranged from $251.25 to $251.31. Afterward, the reported option positions were 611 Stock Option shares and 0 Employee Stock Option shares. Separately, 66,647 common shares were held indirectly through a trust.
TD SYNNEX Corporation (SNX) is the issuer in officer Alim Dhanji’s notice proposing a sale of 3,775 common shares, with an aggregate market value of $909,809.87 and an approximate sale date of October 22, 2026. Morgan Stanley Smith Barney LLC is named as the broker. The share-acquisition entries list 82 shares purchased through the employee stock purchase plan on June 30, 2026, and restricted stock vesting of 1,280 shares on July 2, 2026, plus 1,348 and 1,065 shares on October 15, 2026.
TD SYNNEX Corporation (SNX) lists Dennis Polk, an officer and director, as proposing to sell 3,955 common shares for an aggregate market value of $993,763.75, with an approximate sale date of October 21, 2026. The notice lists an exercise of options under a registered plan for cash and names Morgan Stanley Smith Barney LLC as broker.
TD SYNNEX Corp's President, North America, Reyna Thompson, sold 2,433 common shares in six direct transactions on October 20, 2026, pursuant to a Rule 10b5-1 trading plan adopted January 28, 2026. The six reported prices per share were $244.67, $247.80, $248.53, $249.47, $250.65 and $251.11; $247.80, $248.53 and $249.47 were weighted averages for sales within stated price ranges.
TD SYNNEX Corporation officer Reyna Thompson reported a proposed sale of 2,433 common shares, with an aggregate market value of $604,770.81 and an approximate sale date of October 20, 2026. The shares were acquired upon vesting of restricted stock awards from October 3, 2025, through October 15, 2025. The proposed sale is listed through Morgan Stanley Smith Barney LLC on the NYSE.
On October 15, 2026, TD SYNNEX (SNX) Chief Accounting Officer John Paul Henry reported 370 shares of common stock delivered or withheld for payment of exercise price or tax liability across three entries. He also acquired 900 shares of restricted stock under the 2020 Stock Incentive Plan. The transactions were direct, and no Rule 10b5-1 plan is reported.
TD SYNNEX Corp. Chief Human Resources Officer Dhanji Alim reported a 4,174-share restricted-stock award on October 15, 2026, and two entries of 875 and 692 shares delivered or withheld for payment of exercise price or tax liability, both reported at $255.14 per share. The restricted stock was awarded under the 2020 Stock Incentive Plan and vests as to one-third of the shares on each of the first three anniversaries of the grant date.
TD SYNNEX Corp. President, North America Reyna Thompson reported a direct award of 4,350 restricted stock shares on October 15, 2026, under the 2020 Stock Incentive Plan. She also reported 742 and 841 common shares delivered or withheld for payment of exercise price or tax liability, respectively, on that date; both entries list a price of $255.14 per share. No Rule 10b5-1 plan is reported for these transactions.